News

ImmunoScape presented new preclinical data at the AACR Annual Meeting 2026

Apr 25, 2026

ImmunoScape presented new preclinical data at the AACR Annual Meeting 2026, highlighting the potential of its Seed and Boost™ platform in solid...

ImmunoScape Announces Memorandum of Understanding for Clinical Trial with Premier U.S. Cancer Center

Mar 4, 2026

The company also announced a strategic investment from Leonardo DiCaprio SINGAPORE and SAN DIEGO– ImmunoScape Pte. Ltd., an A*STAR spin-out...

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

Nov 13, 2025

“Seed-and-Boost” Approach with Breakthrough Potential, Poised to Transform the Cancer Immunotherapy Landscape SINGAPORE — ImmunoScape Pte....

Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors

Nov 4, 2025

Exclusive collaboration and license agreement focuses on advancing novel, T cell therapy “Seed-and-Boost” approach exploiting the mechanism of the...